The Lymphoma Research Foundation's annual Gala is a major source of funding for lymphoma research.
New York, NY (PRWEB) October 03, 2013
The Lymphoma Research Foundation (LRF) – the nation’s largest non-profit organization devoted exclusively to funding innovative research and serving the lymphoma community through a comprehensive series of education programs, outreach initiatives and patient services – will host its annual gala on October 8, 2013 at New York City’s Chelsea Piers. Hundreds of LRF supporters will celebrate the contributions the evening’s honorees have made in advancing the Foundation’s mission to eradicate lymphoma and serve those touched by the disease.
“The Lymphoma Research Foundation’s annual Gala is an important event, not only for the organization but for the entire lymphoma community,” said Steven J. Prince, LRF Chairman of the Board. “A cure for lymphoma can only be realized through advanced cancer research; and LRF’s Gala is a major source of funding for lymphoma research.”
Dr. Bruce Cheson, former Chair of the Lymphoma Research Foundation’s Scientific Advisory Board and Deputy Chief, Division of Hematology-Oncology and Head of Hematology at the Lombardi Comprehensive Care Center at Georgetown University Hospital, along with his wife Christine will receive this year’s Distinguished Service Award. The award acknowledges the impact of all that the Chesons have done to advance lymphoma research, most notably their founding of LRF’s successful Lymphoma Research Ride in Montgomery County, MD which has raised more than $3 million for lymphoma research over the past seven years. This year’s Corporate Leadership Award will be presented to Millennium: The Takeda Oncology Company for its efforts to advance the Foundation’s overall mission. Through its partnership, Millennium generously supports educational programs and services for patients, continuing educational programs for healthcare providers, and lymphoma research programs.
“I am honored to be a part of this year’s Gala and recognize the significant impact that the Chesons and Millennium: The Takeda Oncology Company have made in lymphoma research through their partnerships with the Foundation,” said Elizabeth Thompson, LRF’s Chief Executive Officer. “I am confident that their continued investments in lymphoma research will bring us closer to finding a cure, while also providing hope to the more than 200 people diagnosed each day with a type of lymphoma.”
Sotheby’s C. Hugh Hildesley will serve as the gala’s auctioneer for both the live auction, as well as for the Foundation’s signature Raise it for Research. During this unique and exciting auction last year, attendees pledged funds for lymphoma research ranging from $500 to $50,000 and raised $300,000 in minutes. The Lymphoma Research Foundation hopes for another successful Raise it for Research at this year’s gala. Funds raised at the gala support LRF’s mission.
“I am honored to be involved with the Lymphoma Research Foundation’s two largest fundraisers – the Gala and the Lymphoma Research Ride,” Dr. Cheson said. “Events such as these raise critical funds that enable us to advance research and develop improved therapies for lymphoma patients.”
The 2013 gala is co-chaired by Barbara & Jerry Freundlich and Susan & Jeffrey Sussman. The Freundlichs founded the Cure for Lymphoma, a predecessor of the Lymphoma Research Foundation; and the Sussmans are corporate leaders, with Jeffrey Sussman founding the Louis Dreyfus Property Group over 40 years ago and has since gone on to establish Property Group Partners.
“Both the Freundlichs and the Sussmans are leaders and visionaries who have remained dedicated to finding a cure for lymphoma,” Thompson said. “With their leadership, this year’s Gala is set to be the best one yet, raising critical funds for innovative and life-changing lymphoma research.”
For more information about the Lymphoma Research Foundation’s annual gala or to purchase tickets to the event, please contact Taylor Zitay at (646) 465-9103 or visit lymphoma.org/gala.
About the Lymphoma Research Foundation
The Lymphoma Research Foundation (LRF) is the nation’s largest non-profit organization devoted to funding innovative research and serving the lymphoma community through a comprehensive series of education programs, outreach initiatives and patient services. To date, LRF has awarded more than $54 million in lymphoma-specific research.
For additional information on LRF’s research, education and services, visit lymphoma.org.